HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marie-Lyse Vanderhaegen Selected Research

JNJ-26483327

9/2014Nanosuspension for the delivery of a poorly soluble anti-cancer kinase inhibitor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Marie-Lyse Vanderhaegen Research Topics

Disease

1Neoplasms (Cancer)
09/2014

Drug/Important Bio-Agent (IBA)

1JNJ-26483327IBA
09/2014
1Phosphotransferases (Kinase)IBA
09/2014

Therapy/Procedure

1Oral Administration
09/2014
1Intravenous Injections
09/2014